News UK MHRA authorises orforglipron private prescription Eli Lilly has announced that orforglipron (Foundayo) is now available to be prescribed for eligible adults via private prescription.
Patients Do we need to rethink the role of private healthcare in pati... Timely patient access to medication has become an acute problem in the UK healthcare system, with patients often caught in a tug-of-war between an overburdened NHS and the high costs of tra
Patients Digital skills: Why private clinics need effective communica... Recent studies have revealed that many UK families are unable to engage in today's digital society due to a lack of online
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.